Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Boswellia serrata resin extract

EU orphan designation number: EU/3/02/117
Active ingredient: Boswellia serrata resin extract
Indication: Treatment of peritumoral oedema derived from brain tumours
Sponsor: Pharmasan GmbH
Obere Hardtstrasse 18, D-79114 Freiburg, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
23/10/2002 Orphan designation EMEA/OD/006/02 (2002)4108 of 21/10/2002
28/11/2006 Removal of orphan designation from Community Register